Skip to Main Content
Try STAT+ TODAY
Trending:
Coronavirus
First Opinion
Biotech
Health
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Politics
STAT+

Hundreds of chimps at the NIH await retirement. This senator wants to help

By Ike Swetlitz Aug. 21, 2018

Reprints
Chimp Rehab
Chimps gather food at Chimp Haven, the national sanctuary for chimpanzees retired from federal research, in Keithville, La. Gerald Herbert/AP

WASHINGTON — Sen. Bill Cassidy is trying to help hundreds of chimpanzees enjoy an easy retirement in his home state of Louisiana.

The Republican is pushing for an amendment to a major appropriations bill winding its way through Congress this week that would force the National Institutes of Health to make good on a 2015 promise to move all its chimps out of research facilities.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Ike Swetlitz

Washington Correspondent

Ike is a Washington correspondent, reporting at the intersection of life science and national politics.

Tags

Trending
Eli Lilly headquarters
FDA approves Lilly diabetes drug that analysts expect to…
FDA approves Lilly diabetes drug that analysts expect to be a big seller
nurse RaDonda Vaught
The case of RaDonda Vaught highlights a double standard…
The case of RaDonda Vaught highlights a double standard for nurses and physicians
What the current spike in Covid-19 cases could say…
What the current spike in Covid-19 cases could say about the coronavirus’ future
Recommended
Senate FDA legislation will include dietary supplement, cosmetic reforms
Senate FDA legislation will include dietary supplement, cosmetic reforms
Publication of the ‘Google Maps’ of human cells is…
Publication of the ‘Google Maps’ of human cells is a milestone. A pioneer of the project…
Dr. Oz is running for Senate
Dr. Oz peddles medical misinformation — but could his…
Dr. Oz peddles medical misinformation — but could his political rise have a silver lining for…

Recommended Stories

Exclusive

Senate FDA legislation will include dietary supplement, cosmetic reforms

By Nicholas Florko

Rachel Haurwitz of Caribou Biosciences
Biotech

A Caribou CAR-T treatment, backed by Nobel-winning science, shows blood-cancer remissions in first data reveal

By Adam Feuerstein

Roche HQ
Biotech

Roche anti-TIGIT cancer immunotherapy fails second clinical trial, raising doubts about drug class

By Adam Feuerstein

Biotech

A new biotech investment firm, headed by a pair of noteworthy VCs, seeks to ‘free the founders’

By Allison DeAngelis

Special Report

From burst bubble to medical marvel: How lipid nanoparticles became the future of gene therapy

By Megan Molteni